Jetrea Side Effects
Generic Name: ocriplasmin ophthalmic
Note: This page contains information about the side effects of ocriplasmin ophthalmic. Some of the dosage forms included on this document may not apply to the brand name Jetrea.
Not all side effects for Jetrea may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.
For the Consumer
Applies to ocriplasmin ophthalmic: intraocular solution
In addition to its needed effects, some unwanted effects may be caused by ocriplasmin ophthalmic (the active ingredient contained in Jetrea). In the event that any of these side effects do occur, they may require medical attention.
If any of the following side effects occur while taking ocriplasmin ophthalmic, check with your doctor or nurse immediately:More common
- Bloody eyes
- blurred vision or other change in vision
- decreased vision
- eye pain
- redness of the eye
- seeing flashes or sparks of light
- sensitivity of the eye to light
- Change in color vision
- difficulty seeing at night
- eye discomfort
- loss of vision
- seeing floating spots before the eyes, or a veil or curtain appearing across part of vision
- throbbing pain
Some of the side effects that can occur with ocriplasmin ophthalmic may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:Less common
- Dry eyes
For Healthcare Professionals
Applies to ocriplasmin ophthalmic: intravitreal solution
Very common (10% or more): Vitreous floaters, eye pain, conjunctival hemorrhage
Common (1% to 10%): Intraocular inflammation, decreased best corrected visual acuity (BCVA), increased intraocular pressure, intraocular hemorrhage, dyschromatopsia, retinal tear, retinal detachment, macular edema, anterior chamber cell, photophobia, vitreous detachment, ocular discomfort, iritis, cataract, dry eye, metamorphopsia, conjunctival hyperemia, retinal degeneration, visual impairment, blurred vision, retinal hemorrhage, vitreous hemorrhage, macular hole, macular degeneration, retinal edema, retinal pigment epitheliopathy, vitreous adhesions, conjunctival edema, eyelid edema, vitritis, anterior chamber flare, ocular sensation in eyes, eye pruritus
Uncommon (0.1% to 1%): Transient blindness, lens subluxation, scotoma, visual field defect, diplopia, hyphema, miosis, unequal pupils, corneal abrasion, anterior chamber inflammation, eye inflammation, conjunctival irritation[Ref]
1. "Product Information. Jetrea (ocriplasmin ophthalmic)." ThromboGenics Inc, Iselin, NJ.
More about Jetrea (ocriplasmin ophthalmic)
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.